1. Home
  2. AXSM vs BRZE Comparison

AXSM vs BRZE Comparison

Compare AXSM & BRZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • BRZE
  • Stock Information
  • Founded
  • AXSM 2012
  • BRZE 2011
  • Country
  • AXSM United States
  • BRZE United States
  • Employees
  • AXSM N/A
  • BRZE N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • BRZE Computer Software: Prepackaged Software
  • Sector
  • AXSM Health Care
  • BRZE Technology
  • Exchange
  • AXSM Nasdaq
  • BRZE Nasdaq
  • Market Cap
  • AXSM 4.0B
  • BRZE 3.8B
  • IPO Year
  • AXSM 2015
  • BRZE 2021
  • Fundamental
  • Price
  • AXSM $93.19
  • BRZE $35.57
  • Analyst Decision
  • AXSM Strong Buy
  • BRZE Strong Buy
  • Analyst Count
  • AXSM 14
  • BRZE 17
  • Target Price
  • AXSM $125.67
  • BRZE $60.18
  • AVG Volume (30 Days)
  • AXSM 427.1K
  • BRZE 989.4K
  • Earning Date
  • AXSM 11-04-2024
  • BRZE 09-05-2024
  • Dividend Yield
  • AXSM N/A
  • BRZE N/A
  • EPS Growth
  • AXSM N/A
  • BRZE N/A
  • EPS
  • AXSM N/A
  • BRZE N/A
  • Revenue
  • AXSM $291,489,000.00
  • BRZE $535,871,000.00
  • Revenue This Year
  • AXSM $42.50
  • BRZE $25.38
  • Revenue Next Year
  • AXSM $69.28
  • BRZE $20.69
  • P/E Ratio
  • AXSM N/A
  • BRZE N/A
  • Revenue Growth
  • AXSM 59.73
  • BRZE 31.12
  • 52 Week Low
  • AXSM $55.02
  • BRZE $33.93
  • 52 Week High
  • AXSM $98.40
  • BRZE $61.53
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 64.50
  • BRZE 31.73
  • Support Level
  • AXSM $88.04
  • BRZE $42.19
  • Resistance Level
  • AXSM $97.00
  • BRZE $44.18
  • Average True Range (ATR)
  • AXSM 3.03
  • BRZE 1.81
  • MACD
  • AXSM 0.49
  • BRZE -0.68
  • Stochastic Oscillator
  • AXSM 64.58
  • BRZE 9.48

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates a majority of its revenue from the United States.

Share on Social Networks: